MEDNAX, Inc. (NYSE:NYSE:MD) Q1 2022 Earnings Conference Call April 28, 2022, 09:00 ET Company Participants Charles Lynch - SVP, Finance, Strategy & IR Mark Ordan - CEO & Director.
Mednax ®, Inc., its clinical leadership, and that of its affiliated Pediatrix ® and Obstetrix ® Medical Groups today provided full support of the Centers for Disease Control and Prevention and other medical associations’ recommendations that all eligible Americans become vaccinated against COVID-19. This recommendation is also consistent with that of.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the MEDNAX Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] And as a reminder, this call is being recorded. I d now like to turn the conference over to our host, Mr. Charles Lynch. Please go ahead, sir.
Charles W. Lynch
Senior VP of Finance, Strategy & IR
Thank you, and good morning, everyone. Thanks for joining our call. I ll quickly read through our forward-looking statements and then turn the call over to Mark. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by MEDNAX s management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-lookin